The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma

Outcomes in multiple myeloma (MM) have improved dramatically in the last two decades with the advent of novel therapies including immunomodulatory agents (IMiDs), proteasome inhibitors and monoclonal antibodies. In recent years, immunotherapy for the treatment of MM has advanced rapidly, with the ap...

Full description

Saved in:
Bibliographic Details
Published in:J Immunother Cancer
Main Authors: Shah, Nina, Aiello, Jack, Avigan, David E, Berdeja, Jesus G, Borrello, Ivan M, Chari, Ajai, Cohen, Adam D, Ganapathi, Karthik, Gray, Lissa, Green, Damian, Krishnan, Amrita, Lin, Yi, Manasanch, Elisabet, Munshi, Nikhil C, Nooka, Ajay K, Rapoport, Aaron P, Smith, Eric L, Vij, Ravi, Dhodapkar, Madhav
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2020
Subjects:
Position Article and Guidelines
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7359060/
https://ncbi.nlm.nih.gov/pubmed/32661116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000734
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items